Silva Ivan Tramujas da Costa e, Araújo José de Ribamar, Andrade Rosilene Viana de, Cabral Celso Rômulo Barbosa, Gimenez Felicidad Santos, Guimarães Adriana Gonçalves Daumas Pinheiro, Martins Ticiane Costa, Lopes Lucília Rocha, Ferreira Luiz Carlos de Lima
Outpatient Clinic of Coloproctology, Manaus, AM, Brazil.
Acta Cir Bras. 2011 Feb;26(1):64-71. doi: 10.1590/s0102-86502011000100012.
To investigate the prevalence of anal squamous intraepithelial lesions (ASIL) or anal cancer in patients attended at the Tropical Medicine Foundation of Amazonas.
344 patients consecutively attended at the institution, in 2007/2008, were distributed in the following strata according to presence/abscense of at risk conditions for anal cancer: Group 1 - HIV-positive men-who-have-sex-with-men (101); Group 2 - HIV-positive females (49); Group 3 - patients without any at risk condition for anal cancer (53); Group 4 - HIV-positive heterosexual men (38); Group 5 - HIV-negative patients, without anoreceptive sexual habits, but with other at risk conditions for anal cancer (45); Group 6 - HIV-negative men-who-have-sex-with-men (26); and Group 7 - HIV-negative anoreceptive females (32). The histopathological results of biopsies guided by high-resolution anoscopy were analyzed by frequentist and bayesian statistics in order to calculate the point-prevalence of ASIL/cancer and observe any eventual preponderance of one group over the other.
The point-prevalence of ASIL for all the patients studied was 93/344 (27%), the difference between HIV-positive and negative patients being statistically significant (38.3% versus 13.5%; p < 0.0001). The prevalence of ASIL for each one of the groups studied was: Group 1 = 49.5%, Group 2 = 28.6%, Group 3 = 3.8%, Group 4 = 21.1%, Group 5 = 11.1%, Group 6 = 30.8% and Group 7 = 18.8%. Standard residual analysis demonstrated that ASIL was significantly prevalent in patients of Group 1 and high-grade ASIL in patients of Group 2. The odds for ASIL of Group 1 was significantly higher in comparison to Groups 2, 3, 4, 5 and 7 (p < 0.03). The odds for ASIL of Groups 2, 4 and 6 were significantly higher in comparison to Group 3 (p < 0.03).
In the patients studied, ASIL (low and/or high-grade) tended to be significantly more prevalent in HIV-positive patients. Nonetheless, HIV-negative anoreceptive patients also presented great probability to have anal cancer precursor lesions, mainly those of the male gender.
调查在亚马孙热带医学基金会就诊的患者中肛门鳞状上皮内病变(ASIL)或肛门癌的患病率。
2007/2008年在该机构连续就诊的344例患者,根据是否存在肛门癌风险因素分为以下几组:第1组——男男性行为的HIV阳性者(101例);第2组——HIV阳性女性(49例);第3组——无任何肛门癌风险因素的患者(53例);第4组——HIV阳性异性恋男性(38例);第5组——HIV阴性、无肛门性行为习惯但有其他肛门癌风险因素的患者(45例);第6组——HIV阴性男男性行为者(26例);第7组——HIV阴性有肛门性行为的女性(32例)。对高分辨率肛门镜引导下活检的组织病理学结果进行频率统计和贝叶斯统计分析,以计算ASIL/癌症的点患病率,并观察是否有一组相对于另一组存在任何最终优势。
所有研究患者的ASIL点患病率为93/344(27%),HIV阳性和阴性患者之间的差异具有统计学意义(38.3%对13.5%;p<0.0001)。所研究的每组患者的ASIL患病率分别为:第1组=49.5%,第2组=28.6%,第3组=3.8%,第4组=21.1%,第5组=11.1%,第6组=30.8%,第7组=18.8%。标准残差分析表明,第1组患者中ASIL显著流行,第2组患者中高级别ASIL显著流行。第1组ASIL的比值与第2、3、4、5和7组相比显著更高(p<0.03)。第2、4和6组ASIL的比值与第3组相比显著更高(p<0.03)。
在所研究的患者中,ASIL(低级别和/或高级别)在HIV阳性患者中往往显著更普遍。尽管如此,HIV阴性有肛门性行为的患者也有很大概率患有肛门癌前驱病变,主要是男性患者。